Drawing for SUREXEVO

USPTO serial 79446428

SUREXEVO

Reviewed by CopyMark Law Group

Reg. 8465864Status 700Registered
Filing date
Status date
Registration date
Sep 29, 2026
Examiner
WILLIS, ALLYSON B
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SUREXEVO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Utsav Mukherjee

Utsav Mukherjee One Juris PC5233 Fresno AvenueRichmond, CA 94804United States

Goods and services

ClassDescriptionStatusFirst use
005Chemical reagents for medical or veterinary purposes; biological preparations for use in cell cultures for medical purposes; diagnostic preparations for medical purposes; diagnostic reagents for medical purposes; diagnostic biomarker reagents for medical purposes; genetic identity tests comprised of reagents for medical purposes; reagents for medical purposes; diagnostic preparations for medical and veterinary purposes; reagents for use in medical genetic testing; pharmaceutical preparations for the treatment and prevention of viral and infectious diseases; chemical preparations for medical purposes, namely, for the treatment and prevention of viral and infectious diseases; enzyme preparations for medical purposes; immunoassay reagents for medical purposes.ACTIVE—
009Data processing apparatus; downloadable computer operating programs; recorded computer operating programs; recorded computer software for detecting genetic sequences; recorded computer software for detecting and measuring antibody levels; downloadable computer software for detecting genetic sequences; downloadable computer software for detecting and measuring antibody levels; recorded computer programs for detecting genetic sequences; recorded computer programs for detecting and measuring antibody levels; downloadable computer programs for detecting genetic sequences;downloadable computer programs for detecting and measuring antibody levels; downloadable computer software for database management; recorded computer software for database management; DNA chips; DNA microarrays for laboratory use; laboratory devices for detecting genetic sequences; gene amplifiers, namely, gene amplification apparatus for scientific research in laboratories; apparatus and instruments for physics for extracting nucleic acid for laboratory use; medical laboratory research instruments for detecting pathogens; chemistry apparatus and instruments, namely, beakers, test tubes, and laboratory pipettes; chromatography apparatus for laboratory use; diagnostic apparatus for research laboratory use for DNA analysis; devices for analyzing genome information, namely, laboratory devices for detecting genetic sequences; nucleic acid sequencers for scientific purposes; biochips for research or scientific purposes; biochip sensors for scientific useACTIVE—
010Testing apparatus for medical purposes, namely, for detecting and measuring antibody levels; medical apparatus and instruments, namely, medical diagnostic apparatus for nucleic acid and genetic testing; apparatus for use in medical analysis in the nature of hematology analyzers; apparatus for blood analysis; apparatus for DNA and RNA testing for medical purposes; body composition analyzers for medical use; medical diagnostic apparatus for the detection of abnormal prion protein; diagnostic apparatus for medical purposes for detecting biomarkers; diagnostic apparatus for medical purposes for detecting viruses; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; genetic testing apparatus for medical purposes; analyzers for bacterial identification for medical purposes.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 29, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 29, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 11, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 11, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 5, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 15, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 14, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 14, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 14, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 18, 2026RFNTREFUSAL PROCESSED BY IB—
Jun 4, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 4, 2026RFRRREFUSAL PROCESSED BY MPU—
Apr 23, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 22, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 20, 2026DOCKASSIGNED TO EXAMINER—
Mar 27, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 27, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 26, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance